These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2653696)

  • 21. Quinolones in the aged.
    Nicolle LE
    Drugs; 1999; 58 Suppl 2():49-51. PubMed ID: 10553705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penetration of rufloxacin into human prostatic tissue and fluid.
    Boerema JB; Bach D; Jol C; Pahlmann W
    J Antimicrob Chemother; 1991 Oct; 28(4):547-54. PubMed ID: 1662190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue distribution and disposition kinetics of enrofloxacin in healthy and E. coli infected broilers.
    Soliman GA
    Dtsch Tierarztl Wochenschr; 2000 Jan; 107(1):23-7. PubMed ID: 10689795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unique aspects of quinolone pharmacokinetics.
    Lode H; Höffken G; Borner K; Koeppe P
    Clin Pharmacokinet; 1989; 16 Suppl 1():1-4. PubMed ID: 2653691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinolones in the elderly.
    Bergan T
    Drugs; 1995; 49 Suppl 2():112-4. PubMed ID: 8549278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids.
    Okezaki E; Terasaki T; Nakamura M; Nagata O; Kato H; Tsuji A
    Drug Metab Dispos; 1988; 16(6):865-74. PubMed ID: 2907467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penetration of fleroxacin into body tissues and fluids.
    Weidekamm E; Portmann R
    Am J Med; 1993 Mar; 94(3A):75S-80S. PubMed ID: 8452186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic considerations in quinolone therapy.
    Nightingale CH
    Pharmacotherapy; 1993; 13(2 Pt 2):34S-38S. PubMed ID: 8474936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic disposition of the new fluoroquinolone antibacterial agent DW116 in rats.
    Park YH; Jung BH; Chung BC; Park J; Mitoma C
    Drug Metab Dispos; 1997 Sep; 25(9):1101-3. PubMed ID: 9311628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biliary elimination and hepatic disposition of a new fluoroquinolone, temafloxacin: experimental evaluation.
    Brogard JM; Koechlin C; Westphal JF; Blicklé JF; Dorner M; Jehl F
    Drugs Exp Clin Res; 1990; 16(8):407-16. PubMed ID: 2097145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic evaluation of enrofloxacin in chickens.
    Abd el-Aziz MI; Aziz MA; Soliman FA; Afify NA
    Br Poult Sci; 1997 May; 38(2):164-8. PubMed ID: 9158891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of rosoxacin in human volunteers.
    Park GB; Saneski J; Weng T; Edelson J
    J Pharm Sci; 1982 Apr; 71(4):461-2. PubMed ID: 7086661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinolone antibacterials. An update of their pharmacology and therapeutic use.
    von Rosenstiel N; Adam D
    Drugs; 1994 Jun; 47(6):872-901. PubMed ID: 7521829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinolone disposition in the elderly. Practical implications.
    Nilsson-Ehle I; Ljungberg B
    Drugs Aging; 1991; 1(4):279-88. PubMed ID: 1794020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic and residue studies of quinolone compounds and olaquindox in poultry.
    Anadón A; Martinez-Larrañaga MR; Diaz MJ; Velez C; Bringas P
    Ann Rech Vet; 1990; 21 Suppl 1():137S-144S. PubMed ID: 2080842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug disposition in the neonatal animal, with particular reference to the foal.
    Baggot JD; Short CR
    Equine Vet J; 1984 Jul; 16(4):364-7. PubMed ID: 6479135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacokinetics in patients with burns.
    Jaehde U; Sörgel F
    Clin Pharmacokinet; 1995 Jul; 29(1):15-28. PubMed ID: 7586895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of quinolones with special reference to the respiratory tree.
    Decré D; Bergogne-Bérézin E
    J Antimicrob Chemother; 1993 Mar; 31(3):331-43. PubMed ID: 8486568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses.
    Giguère S; Sweeney RW; Bélanger M
    Am J Vet Res; 1996 Jul; 57(7):1025-30. PubMed ID: 8807015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Jaehde U; Reiter A; Naber KG; Rodamer M; Sörgel F
    Br J Clin Pharmacol; 2010 Feb; 69(2):167-78. PubMed ID: 20233180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.